Galiciana. Patrimonio Digital de Galicia > Datos de registro

Galego
Castellano
Portugues

Está en:  › Datos de registro

Linked Open Data

3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress

Identificadores del recurso

Current Issues In Molecular Biology, 44(5): 2175-2185 (2022)

14673037

http://hdl.handle.net/11093/3599

10.3390/cimb44050147

https://www.mdpi.com/1467-3045/44/5/147

Procedencia

Ficha

Título:: 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress
Tema:: 2302.14 Glúcidos; 2302 Bioquímica; 3309.03 Antioxidantes en Los Alimentos
Descripción:: The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2.; University of Macau | Ref. SRG2019-00154-ICMS; University of Macau | Ref. MYRG2019-00157-ICMS; University of Macau | Ref. MYRG2018-00169-ICMS; Science and Technology Development Fund | Ref. 0117/2020/A; Science and Technology Development Fund | Ref. SKL-QRCM(UM)-2020–2022; Science and Technology Development Fund | Ref. 0098/2020/A; Ministerio de Ciencia e Innovación | Ref. RYC2020-030365-I
Idioma:: English
Relación:: info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES
Autor/Productor:: Tan, Yi; Miao, Lingchao; Xiao , Jianbo; Cheang, Wai San
Editor:: Current Issues In Molecular Biology; Química analítica e alimentaria; Investigacións Agrarias e Alimentarias
Derechos:: Attribution 4.0 International; https://creativecommons.org/licenses/by/4.0/; openAccess
Fecha:: 2022-06-21T12:09:18Z; 2022-05-12; 2022-06-21T08:37:49Z
Tipo de recurso:: article

oai_dc

<?xml version="1.0" encoding="UTF-8" ?>

< oai_dc:dc schemaLocation =" http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd " >
1. < dc:title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ dc:title >
2. < dc:creator > Tan, Yi </ dc:creator >
3. < dc:creator > Miao, Lingchao </ dc:creator >
4. < dc:creator > Xiao , Jianbo </ dc:creator >
5. < dc:creator > Cheang, Wai San </ dc:creator >
6. < dc:subject > 2302.14 Glúcidos </ dc:subject >
7. < dc:subject > 2302 Bioquímica </ dc:subject >
8. < dc:subject > 3309.03 Antioxidantes en Los Alimentos </ dc:subject >
9. < dc:description > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ dc:description >
10. < dc:description > University of Macau | Ref. SRG2019-00154-ICMS </ dc:description >
11. < dc:description > University of Macau | Ref. MYRG2019-00157-ICMS </ dc:description >
12. < dc:description > University of Macau | Ref. MYRG2018-00169-ICMS </ dc:description >
13. < dc:description > Science and Technology Development Fund | Ref. 0117/2020/A </ dc:description >
14. < dc:description > Science and Technology Development Fund | Ref. SKL-QRCM(UM)-2020–2022 </ dc:description >
15. < dc:description > Science and Technology Development Fund | Ref. 0098/2020/A </ dc:description >
16. < dc:description > Ministerio de Ciencia e Innovación | Ref. RYC2020-030365-I </ dc:description >
17. < dc:date > 2022-06-21T12:09:18Z </ dc:date >
18. < dc:date > 2022-06-21T12:09:18Z </ dc:date >
19. < dc:date > 2022-05-12 </ dc:date >
20. < dc:date > 2022-06-21T08:37:49Z </ dc:date >
21. < dc:type > article </ dc:type >
22. < dc:identifier > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ dc:identifier >
23. < dc:identifier > 14673037 </ dc:identifier >
24. < dc:identifier > http://hdl.handle.net/11093/3599 </ dc:identifier >
25. < dc:identifier > 10.3390/cimb44050147 </ dc:identifier >
26. < dc:identifier > https://www.mdpi.com/1467-3045/44/5/147 </ dc:identifier >
27. < dc:language > eng </ dc:language >
28. < dc:relation > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ dc:relation >
29. < dc:rights > Attribution 4.0 International </ dc:rights >
30. < dc:rights > https://creativecommons.org/licenses/by/4.0/ </ dc:rights >
31. < dc:rights > openAccess </ dc:rights >
32. < dc:publisher > Current Issues In Molecular Biology </ dc:publisher >
33. < dc:publisher > Química analítica e alimentaria </ dc:publisher >
34. < dc:publisher > Investigacións Agrarias e Alimentarias </ dc:publisher >
</ oai_dc:dc >

didl

<?xml version="1.0" encoding="UTF-8" ?>

< d:DIDL schemaLocation =" urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd " >
1. < d:DIDLInfo >
  1. < dcterms:created schemaLocation =" http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd " > 2022-06-21T12:09:18Z </ dcterms:created >
  </ d:DIDLInfo >
2. < d:Item id =" hdl_11093_3599 " >
  1. < d:Descriptor >
    1. < d:Statement mimeType =" application/xml; charset=utf-8 " >
      1. < dii:Identifier schemaLocation =" urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd " > urn:hdl:11093/3599 </ dii:Identifier >
      </ d:Statement >
    </ d:Descriptor >
  2. < d:Descriptor >
    1. < d:Statement mimeType =" application/xml; charset=utf-8 " >
      1. < oai_dc:dc schemaLocation =" http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd " >
        
        < dc:title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ dc:title >
        
        < dc:creator > Tan, Yi </ dc:creator >
        
        < dc:creator > Miao, Lingchao </ dc:creator >
        
        < dc:creator > Xiao , Jianbo </ dc:creator >
        
        < dc:creator > Cheang, Wai San </ dc:creator >
        
        < dc:description > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ dc:description >
        
        < dc:date > 2022-06-21T12:09:18Z </ dc:date >
        
        < dc:date > 2022-06-21T12:09:18Z </ dc:date >
        
        < dc:date > 2022-05-12 </ dc:date >
        
        < dc:date > 2022-06-21T08:37:49Z </ dc:date >
        
        < dc:type > article </ dc:type >
        
        < dc:identifier > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ dc:identifier >
        
        < dc:identifier > 14673037 </ dc:identifier >
        
        < dc:identifier > http://hdl.handle.net/11093/3599 </ dc:identifier >
        
        < dc:identifier > 10.3390/cimb44050147 </ dc:identifier >
        
        < dc:identifier > https://www.mdpi.com/1467-3045/44/5/147 </ dc:identifier >
        
        < dc:language > eng </ dc:language >
        
        < dc:relation > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ dc:relation >
        
        < dc:rights > https://creativecommons.org/licenses/by/4.0/ </ dc:rights >
        
        < dc:rights > openAccess </ dc:rights >
        
        < dc:rights > Attribution 4.0 International </ dc:rights >
        
        < dc:publisher > Current Issues In Molecular Biology </ dc:publisher >
        
        < dc:publisher > Química analítica e alimentaria </ dc:publisher >
        
        < dc:publisher > Investigacións Agrarias e Alimentarias </ dc:publisher >
        
        </ oai_dc:dc >
      </ d:Statement >
    </ d:Descriptor >
  3. < d:Component id =" 11093_3599_1 " >
    1. < d:Resource mimeType =" application/pdf " ref =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/1/Tan_yi_2022_334_Tet_tra.pdf " />
    </ d:Component >
  </ d:Item >
</ d:DIDL >

dim

<?xml version="1.0" encoding="UTF-8" ?>

< dim:dim schemaLocation =" http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd " >
1. < dim:field authority =" 7a3e1df3-1a32-44fa-ad8f-7ede56f1ba98 " confidence =" 500 " element =" contributor " mdschema =" dc " qualifier =" author " > Tan, Yi </ dim:field >
2. < dim:field authority =" 6990757d-0616-4564-a22b-150720e6f689 " confidence =" 500 " element =" contributor " mdschema =" dc " qualifier =" author " > Miao, Lingchao </ dim:field >
3. < dim:field authority =" 8759 " confidence =" 600 " element =" contributor " mdschema =" dc " qualifier =" author " > Xiao , Jianbo </ dim:field >
4. < dim:field authority =" 14c27800-095e-4dd6-a830-7bc118e8ba7f " confidence =" 500 " element =" contributor " mdschema =" dc " qualifier =" author " > Cheang, Wai San </ dim:field >
5. < dim:field element =" date " mdschema =" dc " qualifier =" accessioned " > 2022-06-21T12:09:18Z </ dim:field >
6. < dim:field element =" date " mdschema =" dc " qualifier =" available " > 2022-06-21T12:09:18Z </ dim:field >
7. < dim:field element =" date " mdschema =" dc " qualifier =" issued " > 2022-05-12 </ dim:field >
8. < dim:field element =" date " mdschema =" dc " qualifier =" updated " > 2022-06-21T08:37:49Z </ dim:field >
9. < dim:field element =" identifier " lang =" spa " mdschema =" dc " qualifier =" citation " > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ dim:field >
10. < dim:field element =" identifier " mdschema =" dc " qualifier =" issn " > 14673037 </ dim:field >
11. < dim:field element =" identifier " mdschema =" dc " qualifier =" uri " > http://hdl.handle.net/11093/3599 </ dim:field >
12. < dim:field element =" identifier " mdschema =" dc " qualifier =" doi " > 10.3390/cimb44050147 </ dim:field >
13. < dim:field element =" identifier " lang =" spa " mdschema =" dc " qualifier =" editor " > https://www.mdpi.com/1467-3045/44/5/147 </ dim:field >
14. < dim:field element =" description " lang =" en " mdschema =" dc " qualifier =" abstract " > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ dim:field >
15. < dim:field element =" description " lang =" spa " mdschema =" dc " qualifier =" sponsorship " > University of Macau | Ref. SRG2019-00154-ICMS </ dim:field >
16. < dim:field element =" description " lang =" spa " mdschema =" dc " qualifier =" sponsorship " > University of Macau | Ref. MYRG2019-00157-ICMS </ dim:field >
17. < dim:field element =" description " lang =" spa " mdschema =" dc " qualifier =" sponsorship " > University of Macau | Ref. MYRG2018-00169-ICMS </ dim:field >
18. < dim:field element =" description " lang =" spa " mdschema =" dc " qualifier =" sponsorship " > Science and Technology Development Fund | Ref. 0117/2020/A </ dim:field >
19. < dim:field element =" description " lang =" spa " mdschema =" dc " qualifier =" sponsorship " > Science and Technology Development Fund | Ref. SKL-QRCM(UM)-2020–2022 </ dim:field >
20. < dim:field element =" description " lang =" spa " mdschema =" dc " qualifier =" sponsorship " > Science and Technology Development Fund | Ref. 0098/2020/A </ dim:field >
21. < dim:field element =" description " lang =" spa " mdschema =" dc " qualifier =" sponsorship " > Ministerio de Ciencia e Innovación | Ref. RYC2020-030365-I </ dim:field >
22. < dim:field element =" language " lang =" spa " mdschema =" dc " qualifier =" iso " > eng </ dim:field >
23. < dim:field element =" publisher " lang =" spa " mdschema =" dc " > Current Issues In Molecular Biology </ dim:field >
24. < dim:field element =" publisher " lang =" spa " mdschema =" dc " qualifier =" departamento " > Química analítica e alimentaria </ dim:field >
25. < dim:field element =" publisher " lang =" spa " mdschema =" dc " qualifier =" grupoinvestigacion " > Investigacións Agrarias e Alimentarias </ dim:field >
26. < dim:field element =" relation " mdschema =" dc " > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ dim:field >
27. < dim:field element =" rights " mdschema =" dc " > Attribution 4.0 International </ dim:field >
28. < dim:field element =" rights " mdschema =" dc " qualifier =" uri " > https://creativecommons.org/licenses/by/4.0/ </ dim:field >
29. < dim:field element =" rights " lang =" spa " mdschema =" dc " qualifier =" accessRights " > openAccess </ dim:field >
30. < dim:field element =" title " lang =" en " mdschema =" dc " > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ dim:field >
31. < dim:field element =" type " lang =" spa " mdschema =" dc " > article </ dim:field >
32. < dim:field element =" subject " lang =" spa " mdschema =" dc " qualifier =" unesco " > 2302.14 Glúcidos </ dim:field >
33. < dim:field element =" subject " lang =" spa " mdschema =" dc " qualifier =" unesco " > 2302 Bioquímica </ dim:field >
34. < dim:field element =" subject " lang =" spa " mdschema =" dc " qualifier =" unesco " > 3309.03 Antioxidantes en Los Alimentos </ dim:field >
35. < dim:field element =" computerCitation " lang =" spa " mdschema =" dc " > pub_title=Current Issues In Molecular Biology|volume=44|journal_number=5|start_pag=2175|end_pag=2185 </ dim:field >
</ dim:dim >

etdms

<?xml version="1.0" encoding="UTF-8" ?>

< thesis schemaLocation =" http://www.ndltd.org/standards/metadata/etdms/1.0/ http://www.ndltd.org/standards/metadata/etdms/1.0/etdms.xsd " >
1. < title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ title >
2. < creator > Tan, Yi </ creator >
3. < creator > Miao, Lingchao </ creator >
4. < creator > Xiao , Jianbo </ creator >
5. < creator > Cheang, Wai San </ creator >
6. < description > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ description >
7. < date > 2022-06-21 </ date >
8. < date > 2022-06-21 </ date >
9. < date > 2022-05-12 </ date >
10. < date > 2022-06-21 </ date >
11. < type > article </ type >
12. < identifier > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ identifier >
13. < identifier > 14673037 </ identifier >
14. < identifier > http://hdl.handle.net/11093/3599 </ identifier >
15. < identifier > 10.3390/cimb44050147 </ identifier >
16. < identifier > https://www.mdpi.com/1467-3045/44/5/147 </ identifier >
17. < language > eng </ language >
18. < relation > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ relation >
19. < rights > https://creativecommons.org/licenses/by/4.0/ </ rights >
20. < rights > openAccess </ rights >
21. < rights > Attribution 4.0 International </ rights >
22. < publisher > Current Issues In Molecular Biology </ publisher >
23. < publisher > Química analítica e alimentaria </ publisher >
24. < publisher > Investigacións Agrarias e Alimentarias </ publisher >
</ thesis >

marc

<?xml version="1.0" encoding="UTF-8" ?>

< record schemaLocation =" http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd " >
1. < leader > 00925njm 22002777a 4500 </ leader >
2. < datafield ind1 =" " ind2 =" " tag =" 042 " >
  1. < subfield code =" a " > dc </ subfield >
  </ datafield >
3. < datafield ind1 =" " ind2 =" " tag =" 720 " >
  1. < subfield code =" a " > Tan, Yi </ subfield >
  2. < subfield code =" e " > author </ subfield >
  </ datafield >
4. < datafield ind1 =" " ind2 =" " tag =" 720 " >
  1. < subfield code =" a " > Miao, Lingchao </ subfield >
  2. < subfield code =" e " > author </ subfield >
  </ datafield >
5. < datafield ind1 =" " ind2 =" " tag =" 720 " >
  1. < subfield code =" a " > Xiao , Jianbo </ subfield >
  2. < subfield code =" e " > author </ subfield >
  </ datafield >
6. < datafield ind1 =" " ind2 =" " tag =" 720 " >
  1. < subfield code =" a " > Cheang, Wai San </ subfield >
  2. < subfield code =" e " > author </ subfield >
  </ datafield >
7. < datafield ind1 =" " ind2 =" " tag =" 260 " >
  1. < subfield code =" c " > 2022-05-12 </ subfield >
  </ datafield >
8. < datafield ind1 =" " ind2 =" " tag =" 520 " >
  1. < subfield code =" a " > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ subfield >
  </ datafield >
9. < datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
  1. < subfield code =" a " > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ subfield >
  </ datafield >
10. < datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
  1. < subfield code =" a " > 14673037 </ subfield >
  </ datafield >
11. < datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
  1. < subfield code =" a " > http://hdl.handle.net/11093/3599 </ subfield >
  </ datafield >
12. < datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
  1. < subfield code =" a " > 10.3390/cimb44050147 </ subfield >
  </ datafield >
13. < datafield ind1 =" 8 " ind2 =" " tag =" 024 " >
  1. < subfield code =" a " > https://www.mdpi.com/1467-3045/44/5/147 </ subfield >
  </ datafield >
14. < datafield ind1 =" 0 " ind2 =" 0 " tag =" 245 " >
  1. < subfield code =" a " > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ subfield >
  </ datafield >
</ record >

mets

<?xml version="1.0" encoding="UTF-8" ?>

< mets ID =" DSpace_ITEM_11093-3599 " OBJID =" hdl:11093/3599 " PROFILE =" DSpace METS SIP Profile 1.0 " TYPE =" DSpace ITEM " schemaLocation =" http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd " >
1. < metsHdr CREATEDATE =" 2024-12-31T06:17:51Z " >
  1. < agent ROLE =" CUSTODIAN " TYPE =" ORGANIZATION " >
    1. < name > Investigo </ name >
    </ agent >
  </ metsHdr >
2. < dmdSec ID =" DMD_11093_3599 " >
  1. < mdWrap MDTYPE =" MODS " >
    1. < xmlData schemaLocation =" http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd " >
      1. < mods:mods schemaLocation =" http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd " >
        
        < mods:name >
        
        < mods:role >
        
        < mods:roleTerm type =" text " > author </ mods:roleTerm >
        
        </ mods:role >
        
        < mods:namePart > Tan, Yi </ mods:namePart >
        
        </ mods:name >
        
        < mods:name >
        
        < mods:role >
        
        < mods:roleTerm type =" text " > author </ mods:roleTerm >
        
        </ mods:role >
        
        < mods:namePart > Miao, Lingchao </ mods:namePart >
        
        </ mods:name >
        
        < mods:name >
        
        < mods:role >
        
        < mods:roleTerm type =" text " > author </ mods:roleTerm >
        
        </ mods:role >
        
        < mods:namePart > Xiao , Jianbo </ mods:namePart >
        
        </ mods:name >
        
        < mods:name >
        
        < mods:role >
        
        < mods:roleTerm type =" text " > author </ mods:roleTerm >
        
        </ mods:role >
        
        < mods:namePart > Cheang, Wai San </ mods:namePart >
        
        </ mods:name >
        
        < mods:extension >
        
        < mods:dateAccessioned encoding =" iso8601 " > 2022-06-21T12:09:18Z </ mods:dateAccessioned >
        
        </ mods:extension >
        
        < mods:extension >
        
        < mods:dateAvailable encoding =" iso8601 " > 2022-06-21T12:09:18Z </ mods:dateAvailable >
        
        </ mods:extension >
        
        < mods:originInfo >
        
        < mods:dateIssued encoding =" iso8601 " > 2022-05-12 </ mods:dateIssued >
        
        </ mods:originInfo >
        
        < mods:identifier type =" citation " > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ mods:identifier >
        
        < mods:identifier type =" issn " > 14673037 </ mods:identifier >
        
        < mods:identifier type =" uri " > http://hdl.handle.net/11093/3599 </ mods:identifier >
        
        < mods:identifier type =" doi " > 10.3390/cimb44050147 </ mods:identifier >
        
        < mods:identifier type =" editor " > https://www.mdpi.com/1467-3045/44/5/147 </ mods:identifier >
        
        < mods:abstract > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ mods:abstract >
        
        < mods:language >
        
        < mods:languageTerm authority =" rfc3066 " > eng </ mods:languageTerm >
        
        </ mods:language >
        
        < mods:accessCondition type =" useAndReproduction " > Attribution 4.0 International </ mods:accessCondition >
        
        < mods:titleInfo >
        
        < mods:title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ mods:title >
        
        </ mods:titleInfo >
        
        < mods:genre > article </ mods:genre >
        
        </ mods:mods >
      </ xmlData >
    </ mdWrap >
  </ dmdSec >
3. < amdSec ID =" TMD_11093_3599 " >
  1. < rightsMD ID =" RIG_11093_3599 " >
    1. < mdWrap MDTYPE =" OTHER " MIMETYPE =" text/plain " OTHERMDTYPE =" DSpaceDepositLicense " >
      1. < binData />
      </ mdWrap >
    </ rightsMD >
  </ amdSec >
4. < amdSec ID =" FO_11093_3599_1 " >
  1. < techMD ID =" TECH_O_11093_3599_1 " >
    1. < mdWrap MDTYPE =" PREMIS " >
      1. < xmlData schemaLocation =" http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd " >
        
        < premis:premis >
        
        < premis:object >
        
        < premis:objectIdentifier >
        
        < premis:objectIdentifierType > URL </ premis:objectIdentifierType >
        
        < premis:objectIdentifierValue > https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/1/Tan_yi_2022_334_Tet_tra.pdf </ premis:objectIdentifierValue >
        
        </ premis:objectIdentifier >
        
        < premis:objectCategory > File </ premis:objectCategory >
        
        < premis:objectCharacteristics >
        
        < premis:fixity >
        
        < premis:messageDigestAlgorithm > MD5 </ premis:messageDigestAlgorithm >
        
        < premis:messageDigest > 0bd890194322f9923c862b48a842847c </ premis:messageDigest >
        
        </ premis:fixity >
        
        < premis:size > 1346750 </ premis:size >
        
        < premis:format >
        
        < premis:formatDesignation >
        
        < premis:formatName > application/pdf </ premis:formatName >
        
        </ premis:formatDesignation >
        
        </ premis:format >
        
        </ premis:objectCharacteristics >
        
        < premis:originalName > Tan_yi_2022_334_Tet_tra.pdf </ premis:originalName >
        
        </ premis:object >
        
        </ premis:premis >
        
        </ xmlData >
      </ mdWrap >
    </ techMD >
  </ amdSec >
5. < amdSec ID =" FT_11093_3599_4 " >
  1. < techMD ID =" TECH_T_11093_3599_4 " >
    1. < mdWrap MDTYPE =" PREMIS " >
      1. < xmlData schemaLocation =" http://www.loc.gov/standards/premis http://www.loc.gov/standards/premis/PREMIS-v1-0.xsd " >
        
        < premis:premis >
        
        < premis:object >
        
        < premis:objectIdentifier >
        
        < premis:objectIdentifierType > URL </ premis:objectIdentifierType >
        
        < premis:objectIdentifierValue > https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/4/Tan_yi_2022_334_Tet_tra.pdf.txt </ premis:objectIdentifierValue >
        
        </ premis:objectIdentifier >
        
        < premis:objectCategory > File </ premis:objectCategory >
        
        < premis:objectCharacteristics >
        
        < premis:fixity >
        
        < premis:messageDigestAlgorithm > MD5 </ premis:messageDigestAlgorithm >
        
        < premis:messageDigest > 6c17a7148acb3599f9493a5d07ed52fe </ premis:messageDigest >
        
        </ premis:fixity >
        
        < premis:size > 50114 </ premis:size >
        
        < premis:format >
        
        < premis:formatDesignation >
        
        < premis:formatName > text/plain </ premis:formatName >
        
        </ premis:formatDesignation >
        
        </ premis:format >
        
        </ premis:objectCharacteristics >
        
        < premis:originalName > Tan_yi_2022_334_Tet_tra.pdf.txt </ premis:originalName >
        
        </ premis:object >
        
        </ premis:premis >
        
        </ xmlData >
      </ mdWrap >
    </ techMD >
  </ amdSec >
6. < fileSec >
  1. < fileGrp USE =" ORIGINAL " >
    1. < file ADMID =" FO_11093_3599_1 " CHECKSUM =" 0bd890194322f9923c862b48a842847c " CHECKSUMTYPE =" MD5 " GROUPID =" GROUP_BITSTREAM_11093_3599_1 " ID =" BITSTREAM_ORIGINAL_11093_3599_1 " MIMETYPE =" application/pdf " SEQ =" 1 " SIZE =" 1346750 " >
      1. < FLocat LOCTYPE =" URL " href =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/1/Tan_yi_2022_334_Tet_tra.pdf " type =" simple " />
      </ file >
    </ fileGrp >
  2. < fileGrp USE =" TEXT " >
    1. < file ADMID =" FT_11093_3599_4 " CHECKSUM =" 6c17a7148acb3599f9493a5d07ed52fe " CHECKSUMTYPE =" MD5 " GROUPID =" GROUP_BITSTREAM_11093_3599_4 " ID =" BITSTREAM_TEXT_11093_3599_4 " MIMETYPE =" text/plain " SEQ =" 4 " SIZE =" 50114 " >
      1. < FLocat LOCTYPE =" URL " href =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/4/Tan_yi_2022_334_Tet_tra.pdf.txt " type =" simple " />
      </ file >
    </ fileGrp >
  </ fileSec >
7. < structMap LABEL =" DSpace Object " TYPE =" LOGICAL " >
  1. < div ADMID =" DMD_11093_3599 " TYPE =" DSpace Object Contents " >
    1. < div TYPE =" DSpace BITSTREAM " >
      1. < fptr FILEID =" BITSTREAM_ORIGINAL_11093_3599_1 " />
      </ div >
    </ div >
  </ structMap >
</ mets >

mods

<?xml version="1.0" encoding="UTF-8" ?>

< mods:mods schemaLocation =" http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd " >
1. < mods:name >
  1. < mods:namePart > Tan, Yi </ mods:namePart >
  </ mods:name >
2. < mods:name >
  1. < mods:namePart > Miao, Lingchao </ mods:namePart >
  </ mods:name >
3. < mods:name >
  1. < mods:namePart > Xiao , Jianbo </ mods:namePart >
  </ mods:name >
4. < mods:name >
  1. < mods:namePart > Cheang, Wai San </ mods:namePart >
  </ mods:name >
5. < mods:extension >
  1. < mods:dateAvailable encoding =" iso8601 " > 2022-06-21T12:09:18Z </ mods:dateAvailable >
  </ mods:extension >
6. < mods:extension >
  1. < mods:dateAccessioned encoding =" iso8601 " > 2022-06-21T12:09:18Z </ mods:dateAccessioned >
  </ mods:extension >
7. < mods:originInfo >
  1. < mods:dateIssued encoding =" iso8601 " > 2022-05-12 </ mods:dateIssued >
  </ mods:originInfo >
8. < mods:identifier type =" citation " > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ mods:identifier >
9. < mods:identifier type =" issn " > 14673037 </ mods:identifier >
10. < mods:identifier type =" uri " > http://hdl.handle.net/11093/3599 </ mods:identifier >
11. < mods:identifier type =" doi " > 10.3390/cimb44050147 </ mods:identifier >
12. < mods:identifier type =" editor " > https://www.mdpi.com/1467-3045/44/5/147 </ mods:identifier >
13. < mods:abstract > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ mods:abstract >
14. < mods:language >
  1. < mods:languageTerm > eng </ mods:languageTerm >
  </ mods:language >
15. < mods:accessCondition type =" useAndReproduction " > https://creativecommons.org/licenses/by/4.0/ </ mods:accessCondition >
16. < mods:accessCondition type =" useAndReproduction " > openAccess </ mods:accessCondition >
17. < mods:accessCondition type =" useAndReproduction " > Attribution 4.0 International </ mods:accessCondition >
18. < mods:titleInfo >
  1. < mods:title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ mods:title >
  </ mods:titleInfo >
19. < mods:genre > article </ mods:genre >
</ mods:mods >

ore

<?xml version="1.0" encoding="UTF-8" ?>

< atom:entry schemaLocation =" http://www.w3.org/2005/Atom http://www.kbcafe.com/rss/atom.xsd.xml " >
1. < atom:id > http://hdl.handle.net/11093/3599/ore.xml </ atom:id >
2. < atom:link href =" http://hdl.handle.net/11093/3599 " rel =" alternate " />
3. < atom:link href =" http://hdl.handle.net/11093/3599/ore.xml " rel =" http://www.openarchives.org/ore/terms/describes " />
4. < atom:link href =" http://hdl.handle.net/11093/3599/ore.xml#atom " rel =" self " type =" application/atom+xml " />
5. < atom:published > 2022-06-21T12:09:18Z </ atom:published >
6. < atom:updated > 2022-06-21T12:09:18Z </ atom:updated >
7. < atom:source >
  1. < atom:generator > Investigo </ atom:generator >
  </ atom:source >
8. < atom:title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ atom:title >
9. < atom:author >
  1. < atom:name > Tan, Yi </ atom:name >
  </ atom:author >
10. < atom:author >
  1. < atom:name > Miao, Lingchao </ atom:name >
  </ atom:author >
11. < atom:author >
  1. < atom:name > Xiao , Jianbo </ atom:name >
  </ atom:author >
12. < atom:author >
  1. < atom:name > Cheang, Wai San </ atom:name >
  </ atom:author >
13. < atom:category label =" Aggregation " scheme =" http://www.openarchives.org/ore/terms/ " term =" http://www.openarchives.org/ore/terms/Aggregation " />
14. < atom:category scheme =" http://www.openarchives.org/ore/atom/modified " term =" 2022-06-21T12:09:18Z " />
15. < atom:category label =" DSpace Item " scheme =" http://www.dspace.org/objectModel/ " term =" DSpaceItem " />
16. < atom:link href =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/1/Tan_yi_2022_334_Tet_tra.pdf " length =" 1346750 " rel =" http://www.openarchives.org/ore/terms/aggregates " title =" Tan_yi_2022_334_Tet_tra.pdf " type =" application/pdf " />
17. < oreatom:triples >
  1. < rdf:Description about =" http://hdl.handle.net/11093/3599/ore.xml#atom " >
    1. < rdf:type resource =" http://www.dspace.org/objectModel/DSpaceItem " />
    2. < dcterms:modified > 2022-06-21T12:09:18Z </ dcterms:modified >
    </ rdf:Description >
  2. < rdf:Description about =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/1/Tan_yi_2022_334_Tet_tra.pdf " >
    1. < rdf:type resource =" http://www.dspace.org/objectModel/DSpaceBitstream " />
    2. < dcterms:description > ORIGINAL </ dcterms:description >
    </ rdf:Description >
  3. < rdf:Description about =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/2/license.txt " >
    1. < rdf:type resource =" http://www.dspace.org/objectModel/DSpaceBitstream " />
    2. < dcterms:description > LICENSE </ dcterms:description >
    </ rdf:Description >
  4. < rdf:Description about =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/3/sword.zip " >
    1. < rdf:type resource =" http://www.dspace.org/objectModel/DSpaceBitstream " />
    2. < dcterms:description > SWORD </ dcterms:description >
    </ rdf:Description >
  5. < rdf:Description about =" https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/4/Tan_yi_2022_334_Tet_tra.pdf.txt " >
    1. < rdf:type resource =" http://www.dspace.org/objectModel/DSpaceBitstream " />
    2. < dcterms:description > TEXT </ dcterms:description >
    </ rdf:Description >
  </ oreatom:triples >
</ atom:entry >

qdc

<?xml version="1.0" encoding="UTF-8" ?>

< qdc:qualifieddc schemaLocation =" http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd " >
1. < dc:title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ dc:title >
2. < dc:creator > Tan, Yi </ dc:creator >
3. < dc:creator > Miao, Lingchao </ dc:creator >
4. < dc:creator > Xiao , Jianbo </ dc:creator >
5. < dc:creator > Cheang, Wai San </ dc:creator >
6. < dcterms:abstract > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ dcterms:abstract >
7. < dcterms:dateAccepted > 2022-06-21T12:09:18Z </ dcterms:dateAccepted >
8. < dcterms:available > 2022-06-21T12:09:18Z </ dcterms:available >
9. < dcterms:created > 2022-06-21T12:09:18Z </ dcterms:created >
10. < dcterms:issued > 2022-05-12 </ dcterms:issued >
11. < dc:type > article </ dc:type >
12. < dc:identifier > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ dc:identifier >
13. < dc:identifier > 14673037 </ dc:identifier >
14. < dc:identifier > http://hdl.handle.net/11093/3599 </ dc:identifier >
15. < dc:identifier > 10.3390/cimb44050147 </ dc:identifier >
16. < dc:identifier > https://www.mdpi.com/1467-3045/44/5/147 </ dc:identifier >
17. < dc:language > eng </ dc:language >
18. < dc:relation > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ dc:relation >
19. < dc:rights > https://creativecommons.org/licenses/by/4.0/ </ dc:rights >
20. < dc:rights > openAccess </ dc:rights >
21. < dc:rights > Attribution 4.0 International </ dc:rights >
22. < dc:publisher > Current Issues In Molecular Biology </ dc:publisher >
23. < dc:publisher > Química analítica e alimentaria </ dc:publisher >
24. < dc:publisher > Investigacións Agrarias e Alimentarias </ dc:publisher >
</ qdc:qualifieddc >

rdf

<?xml version="1.0" encoding="UTF-8" ?>

< rdf:RDF schemaLocation =" http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd " >
1. < ow:Publication about =" oai:www.investigo.biblioteca.uvigo.es:11093/3599 " >
  1. < dc:title > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ dc:title >
  2. < dc:creator > Tan, Yi </ dc:creator >
  3. < dc:creator > Miao, Lingchao </ dc:creator >
  4. < dc:creator > Xiao , Jianbo </ dc:creator >
  5. < dc:creator > Cheang, Wai San </ dc:creator >
  6. < dc:description > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ dc:description >
  7. < dc:date > 2022-06-21T12:09:18Z </ dc:date >
  8. < dc:date > 2022-06-21T12:09:18Z </ dc:date >
  9. < dc:date > 2022-05-12 </ dc:date >
  10. < dc:date > 2022-06-21T08:37:49Z </ dc:date >
  11. < dc:type > article </ dc:type >
  12. < dc:identifier > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ dc:identifier >
  13. < dc:identifier > 14673037 </ dc:identifier >
  14. < dc:identifier > http://hdl.handle.net/11093/3599 </ dc:identifier >
  15. < dc:identifier > 10.3390/cimb44050147 </ dc:identifier >
  16. < dc:identifier > https://www.mdpi.com/1467-3045/44/5/147 </ dc:identifier >
  17. < dc:language > eng </ dc:language >
  18. < dc:relation > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ dc:relation >
  19. < dc:rights > https://creativecommons.org/licenses/by/4.0/ </ dc:rights >
  20. < dc:rights > openAccess </ dc:rights >
  21. < dc:rights > Attribution 4.0 International </ dc:rights >
  22. < dc:publisher > Current Issues In Molecular Biology </ dc:publisher >
  23. < dc:publisher > Química analítica e alimentaria </ dc:publisher >
  24. < dc:publisher > Investigacións Agrarias e Alimentarias </ dc:publisher >
  </ ow:Publication >
</ rdf:RDF >

suxi

<?xml version="1.0" encoding="UTF-8" ?>

< oai_dc:dc schemaLocation =" http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd " >
1. < dcterms:dateAccepted > 2022-06-21T12:09:18Z </ dcterms:dateAccepted >
2. < dcterms:available > 2022-06-21T12:09:18Z </ dcterms:available >
3. < dcterms:issued > 2022-05-12 </ dcterms:issued >
4. < dcterms:identifier_bibliographicCitation lang =" spa " > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ dcterms:identifier_bibliographicCitation >
5. < dcterms:identifier_issn > 14673037 </ dcterms:identifier_issn >
6. < dcterms:identifier_doi > 10.3390/cimb44050147 </ dcterms:identifier_doi >
7. < dcterms:identifier type =" dcterms:URI " > http://hdl.handle.net/11093/3599 </ dcterms:identifier >
8. < dcterms:identifier_editor lang =" spa " > https://www.mdpi.com/1467-3045/44/5/147 </ dcterms:identifier_editor >
9. < dcterms:abstract lang =" en " > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ dcterms:abstract >
10. < dcterms:description_sponsorship lang =" spa " > University of Macau | Ref. SRG2019-00154-ICMS </ dcterms:description_sponsorship >
11. < dcterms:description_sponsorship lang =" spa " > University of Macau | Ref. MYRG2019-00157-ICMS </ dcterms:description_sponsorship >
12. < dcterms:description_sponsorship lang =" spa " > University of Macau | Ref. MYRG2018-00169-ICMS </ dcterms:description_sponsorship >
13. < dcterms:description_sponsorship lang =" spa " > Science and Technology Development Fund | Ref. 0117/2020/A </ dcterms:description_sponsorship >
14. < dcterms:description_sponsorship lang =" spa " > Science and Technology Development Fund | Ref. SKL-QRCM(UM)-2020–2022 </ dcterms:description_sponsorship >
15. < dcterms:description_sponsorship lang =" spa " > Science and Technology Development Fund | Ref. 0098/2020/A </ dcterms:description_sponsorship >
16. < dcterms:description_sponsorship lang =" spa " > Ministerio de Ciencia e Innovación | Ref. RYC2020-030365-I </ dcterms:description_sponsorship >
17. < dcterms:language type =" dcterms:ISO639-2 " lang =" spa " > eng </ dcterms:language >
18. < dcterms:publisher lang =" spa " > Current Issues In Molecular Biology </ dcterms:publisher >
19. < dcterms:relation > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ dcterms:relation >
20. < dcterms:rights > Attribution 4.0 International </ dcterms:rights >
21. < dcterms:accessRights lang =" spa " > openAccess </ dcterms:accessRights >
22. < dcterms:rights_uri type =" dcterms:URI " > https://creativecommons.org/licenses/by/4.0/ </ dcterms:rights_uri >
23. < dcterms:title lang =" en " > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ dcterms:title >
24. < dcterms:type lang =" spa " > article </ dcterms:type >
25. < dcterms:computerCitation lang =" spa " > pub_title=Current Issues In Molecular Biology|volume=44|journal_number=5|start_pag=2175|end_pag=2185 </ dcterms:computerCitation >
26. < dcterms:publisher_department lang =" spa " > Química analítica e alimentaria </ dcterms:publisher_department >
27. < dcterms:publisher_group lang =" spa " > Investigacións Agrarias e Alimentarias </ dcterms:publisher_group >
28. < dcterms:subject lang =" spa " > 2302.14 Glúcidos </ dcterms:subject >
29. < dcterms:subject lang =" spa " > 2302 Bioquímica </ dcterms:subject >
30. < dcterms:subject lang =" spa " > 3309.03 Antioxidantes en Los Alimentos </ dcterms:subject >
31. < dcterms:authorList > Tan, Yi#Miao, Lingchao#8759#Cheang, Wai San </ dcterms:authorList >
32. < dcterms:editorList />
</ oai_dc:dc >

xoai

<?xml version="1.0" encoding="UTF-8" ?>

< metadata schemaLocation =" http://www.lyncode.com/xoai http://www.lyncode.com/xsd/xoai.xsd " >
1. < element name =" dc " >
  1. < element name =" contributor " >
    1. < element name =" author " >
      1. < element name =" none " >
        
        < field name =" value " > Tan, Yi </ field >
        
        < field name =" authority " > 7a3e1df3-1a32-44fa-ad8f-7ede56f1ba98 </ field >
        
        < field name =" confidence " > 500 </ field >
        
        < field name =" value " > Miao, Lingchao </ field >
        
        < field name =" authority " > 6990757d-0616-4564-a22b-150720e6f689 </ field >
        
        < field name =" confidence " > 500 </ field >
        
        < field name =" value " > Xiao , Jianbo </ field >
        
        < field name =" authority " > 8759 </ field >
        
        < field name =" confidence " > 600 </ field >
        
        < field name =" value " > Cheang, Wai San </ field >
        
        < field name =" authority " > 14c27800-095e-4dd6-a830-7bc118e8ba7f </ field >
        
        < field name =" confidence " > 500 </ field >
        
        </ element >
      </ element >
    </ element >
  2. < element name =" date " >
    1. < element name =" accessioned " >
      1. < element name =" none " >
        
        < field name =" value " > 2022-06-21T12:09:18Z </ field >
        
        </ element >
      </ element >
    2. < element name =" available " >
      1. < element name =" none " >
        
        < field name =" value " > 2022-06-21T12:09:18Z </ field >
        
        </ element >
      </ element >
    3. < element name =" issued " >
      1. < element name =" none " >
        
        < field name =" value " > 2022-05-12 </ field >
        
        </ element >
      </ element >
    4. < element name =" updated " >
      1. < element name =" none " >
        
        < field name =" value " > 2022-06-21T08:37:49Z </ field >
        
        </ element >
      </ element >
    </ element >
  3. < element name =" identifier " >
    1. < element name =" citation " >
      1. < element name =" spa " >
        
        < field name =" value " > Current Issues In Molecular Biology, 44(5): 2175-2185 (2022) </ field >
        
        </ element >
      </ element >
    2. < element name =" issn " >
      1. < element name =" none " >
        
        < field name =" value " > 14673037 </ field >
        
        </ element >
      </ element >
    3. < element name =" uri " >
      1. < element name =" none " >
        
        < field name =" value " > http://hdl.handle.net/11093/3599 </ field >
        
        </ element >
      </ element >
    4. < element name =" doi " >
      1. < element name =" none " >
        
        < field name =" value " > 10.3390/cimb44050147 </ field >
        
        </ element >
      </ element >
    5. < element name =" editor " >
      1. < element name =" spa " >
        
        < field name =" value " > https://www.mdpi.com/1467-3045/44/5/147 </ field >
        
        </ element >
      </ element >
    </ element >
  4. < element name =" description " >
    1. < element name =" abstract " >
      1. < element name =" en " >
        
        < field name =" value " > The potential anti-diabetic effect of resveratrol derivative, 3,3′,4,5′-tetramethoxy-trans-stilbene (3,3′,4,5′-TMS) and its underlying mechanism in high glucose (HG) and dexamethasone (DXMS)-stimulated insulin-resistant HepG2 cells (IR-HepG2) were investigated. 3,3′,4,5′-TMS did not reduce the cell viability of IR-HepG2 cells at the concentrations of 0.5–10 µM. 3,3′,4,5′-TMS increased the potential of glucose consumption and glycogen synthesis in a concentration-dependent manner in IR-HepG2 cells. 3,3′,4,5′-TMS ameliorated insulin resistance by enhancing the phosphorylation of glycogen synthase kinase 3 beta (GSK3β), inhibiting phosphorylation of insulin receptor substrate-1 (IRS-1), and activating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway in IR-HepG2 cells. Furthermore, 3,3′,4,5′-TMS significantly suppressed levels of reactive oxygen species (ROS) with up-regulation of nuclear factor erythroid 2-related factor 2 (Nrf2) expression. To conclude, the beneficial effect of 3,3′,4,5′-TMS against insulin resistance to increase glucose consumption and glycogen synthesis was mediated through activation of IRS/PI3K/Akt signaling pathways in the IR-HepG2 cells, accomplished with anti-oxidative activity through up-regulation of Nrf2. </ field >
        
        </ element >
      </ element >
    2. < element name =" sponsorship " >
      1. < element name =" spa " >
        
        < field name =" value " > University of Macau | Ref. SRG2019-00154-ICMS </ field >
        
        < field name =" value " > University of Macau | Ref. MYRG2019-00157-ICMS </ field >
        
        < field name =" value " > University of Macau | Ref. MYRG2018-00169-ICMS </ field >
        
        < field name =" value " > Science and Technology Development Fund | Ref. 0117/2020/A </ field >
        
        < field name =" value " > Science and Technology Development Fund | Ref. SKL-QRCM(UM)-2020–2022 </ field >
        
        < field name =" value " > Science and Technology Development Fund | Ref. 0098/2020/A </ field >
        
        < field name =" value " > Ministerio de Ciencia e Innovación | Ref. RYC2020-030365-I </ field >
        
        </ element >
      </ element >
    </ element >
  5. < element name =" language " >
    1. < element name =" iso " >
      1. < element name =" spa " >
        
        < field name =" value " > eng </ field >
        
        </ element >
      </ element >
    </ element >
  6. < element name =" publisher " >
    1. < element name =" spa " >
      1. < field name =" value " > Current Issues In Molecular Biology </ field >
      </ element >
    2. < element name =" departamento " >
      1. < element name =" spa " >
        
        < field name =" value " > Química analítica e alimentaria </ field >
        
        </ element >
      </ element >
    3. < element name =" grupoinvestigacion " >
      1. < element name =" spa " >
        
        < field name =" value " > Investigacións Agrarias e Alimentarias </ field >
        
        </ element >
      </ element >
    </ element >
  7. < element name =" relation " >
    1. < element name =" none " >
      1. < field name =" value " > info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC2020-030365-I/ES </ field >
      </ element >
    </ element >
  8. < element name =" rights " >
    1. < element name =" none " >
      1. < field name =" value " > Attribution 4.0 International </ field >
      </ element >
    2. < element name =" uri " >
      1. < element name =" none " >
        
        < field name =" value " > https://creativecommons.org/licenses/by/4.0/ </ field >
        
        </ element >
      </ element >
    3. < element name =" accessRights " >
      1. < element name =" spa " >
        
        < field name =" value " > openAccess </ field >
        
        </ element >
      </ element >
    </ element >
  9. < element name =" title " >
    1. < element name =" en " >
      1. < field name =" value " > 3,3′,4,5′-Tetramethoxy-trans-stilbene improves insulin resistance by activating the IRS/PI3K/Akt pathway and inhibiting oxidative stress </ field >
      </ element >
    </ element >
  10. < element name =" type " >
    1. < element name =" spa " >
      1. < field name =" value " > article </ field >
      </ element >
    </ element >
  11. < element name =" subject " >
    1. < element name =" unesco " >
      1. < element name =" spa " >
        
        < field name =" value " > 2302.14 Glúcidos </ field >
        
        < field name =" value " > 2302 Bioquímica </ field >
        
        < field name =" value " > 3309.03 Antioxidantes en Los Alimentos </ field >
        
        </ element >
      </ element >
    </ element >
  12. < element name =" computerCitation " >
    1. < element name =" spa " >
      1. < field name =" value " > pub_title=Current Issues In Molecular Biology|volume=44|journal_number=5|start_pag=2175|end_pag=2185 </ field >
      </ element >
    </ element >
  </ element >
2. < element name =" bundles " >
  1. < element name =" bundle " >
    1. < field name =" name " > ORIGINAL </ field >
    2. < element name =" bitstreams " >
      1. < element name =" bitstream " >
        
        < field name =" name " > Tan_yi_2022_334_Tet_tra.pdf </ field >
        
        < field name =" format " > application/pdf </ field >
        
        < field name =" size " > 1346750 </ field >
        
        < field name =" url " > https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/1/Tan_yi_2022_334_Tet_tra.pdf </ field >
        
        < field name =" checksum " > 0bd890194322f9923c862b48a842847c </ field >
        
        < field name =" checksumAlgorithm " > MD5 </ field >
        
        < field name =" sid " > 1 </ field >
        
        < field name =" drm " > open access </ field >
        
        </ element >
      </ element >
    </ element >
  2. < element name =" bundle " >
    1. < field name =" name " > LICENSE </ field >
    2. < element name =" bitstreams " >
      1. < element name =" bitstream " >
        
        < field name =" name " > license.txt </ field >
        
        < field name =" originalName " > license.txt </ field >
        
        < field name =" format " > text/plain; charset=utf-8 </ field >
        
        < field name =" size " > 0 </ field >
        
        < field name =" url " > https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/2/license.txt </ field >
        
        < field name =" checksum " > d41d8cd98f00b204e9800998ecf8427e </ field >
        
        < field name =" checksumAlgorithm " > MD5 </ field >
        
        < field name =" sid " > 2 </ field >
        
        < field name =" drm " > open access </ field >
        
        </ element >
      </ element >
    </ element >
  3. < element name =" bundle " >
    1. < field name =" name " > SWORD </ field >
    2. < element name =" bitstreams " >
      1. < element name =" bitstream " >
        
        < field name =" name " > sword.zip </ field >
        
        < field name =" description " > SWORD deposit package </ field >
        
        < field name =" format " > application/zip </ field >
        
        < field name =" size " > 1208494 </ field >
        
        < field name =" url " > https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/3/sword.zip </ field >
        
        < field name =" checksum " > 2bc0e7aa5ed6c1f090d28df483ca667c </ field >
        
        < field name =" checksumAlgorithm " > MD5 </ field >
        
        < field name =" sid " > 3 </ field >
        
        < field name =" drm " > open access </ field >
        
        </ element >
      </ element >
    </ element >
  4. < element name =" bundle " >
    1. < field name =" name " > TEXT </ field >
    2. < element name =" bitstreams " >
      1. < element name =" bitstream " >
        
        < field name =" name " > Tan_yi_2022_334_Tet_tra.pdf.txt </ field >
        
        < field name =" originalName " > Tan_yi_2022_334_Tet_tra.pdf.txt </ field >
        
        < field name =" description " > Extracted text </ field >
        
        < field name =" format " > text/plain </ field >
        
        < field name =" size " > 50114 </ field >
        
        < field name =" url " > https://www.investigo.biblioteca.uvigo.es/xmlui/bitstream/11093/3599/4/Tan_yi_2022_334_Tet_tra.pdf.txt </ field >
        
        < field name =" checksum " > 6c17a7148acb3599f9493a5d07ed52fe </ field >
        
        < field name =" checksumAlgorithm " > MD5 </ field >
        
        < field name =" sid " > 4 </ field >
        
        < field name =" drm " > open access </ field >
        
        </ element >
      </ element >
    </ element >
  </ element >
3. < element name =" others " >
  1. < field name =" handle " > 11093/3599 </ field >
  2. < field name =" identifier " > oai:www.investigo.biblioteca.uvigo.es:11093/3599 </ field >
  3. < field name =" lastModifyDate " > 2024-11-07 20:04:24.669 </ field >
  4. < field name =" drm " > open access </ field >
  </ element >
4. < element name =" repository " >
  1. < field name =" name " > Investigo </ field >
  2. < field name =" mail " > investigo@uvigo.es </ field >
  </ element >
5. < element name =" license " >
  1. < field name =" bin " />
  </ element >
</ metadata >

Xunta de Galicia. Información mantenida y publicada en internet por la Xunta de Galicia

Atención a la ciudadanía - Accesibilidad - Aviso legal - Mapa del portal